Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gavras

Showing results (161-170 of 312) with videos related to

Pageof 32
Sort By:
The New England Journal of Medicine|October 25, 1984
Renal revascularization in the azotemic hypertensive patient resistant to therapyC Y Ying, C P Tifft, H Gavras, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Clinical application of orally active angiotensin converting enzyme inhibitorsH Gavras, J Biollaz, B Waeber, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1991
Two highly effective V1/V2 antagonists of vasopressin containing novel thioacids at position 1B Lammek, Y X Wang, R Franco, et al.
The Western Journal of Medicine|March 1, 1993
Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?M P Sambhi, H Gavras, J I Robertson, et al.
Biochimica Et Biophysica Acta|March 4, 2000
A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out miceZ Zhao, K Makaritsis, C E Francis, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Models of experimental hypertension in miceC Johns, I Gavras, D E Handy, et al.
Transactions of the Association of American Physicians|January 1, 1978
Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertensionA V Chobanian, H Gavras, J C Melby, et al.
American Journal of Hypertension|September 30, 1998
Renal artery clipping attenuates the progression of adriamycin nephropathyA L Balbi, R J Franco, P Barretti, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1990
Expression of multiple alpha 2-adrenergic receptor messenger RNA species in rat tissuesC S Flordellis, M Castellano, R Franco, et al.
Circulation Research|February 17, 2001
Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertensionI Duka, E Kintsurashvili, I Gavras, et al.
Pageof 32

Showing results (161-170 of 312) with videos related to

Sort By:
Pageof 32
The New England Journal of Medicine|October 25, 1984
Renal revascularization in the azotemic hypertensive patient resistant to therapyC Y Ying, C P Tifft, H Gavras, et al.
Advances in Experimental Medicine and Biology|January 1, 1983
Clinical application of orally active angiotensin converting enzyme inhibitorsH Gavras, J Biollaz, B Waeber, et al.
The Journal of Pharmacy and Pharmacology|January 1, 1991
Two highly effective V1/V2 antagonists of vasopressin containing novel thioacids at position 1B Lammek, Y X Wang, R Franco, et al.
The Western Journal of Medicine|March 1, 1993
Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?M P Sambhi, H Gavras, J I Robertson, et al.
Biochimica Et Biophysica Acta|March 4, 2000
A role for the A3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out miceZ Zhao, K Makaritsis, C E Francis, et al.
Hypertension (Dallas, Tex. : 1979)|December 1, 1996
Models of experimental hypertension in miceC Johns, I Gavras, D E Handy, et al.
Transactions of the Association of American Physicians|January 1, 1978
Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertensionA V Chobanian, H Gavras, J C Melby, et al.
American Journal of Hypertension|September 30, 1998
Renal artery clipping attenuates the progression of adriamycin nephropathyA L Balbi, R J Franco, P Barretti, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1990
Expression of multiple alpha 2-adrenergic receptor messenger RNA species in rat tissuesC S Flordellis, M Castellano, R Franco, et al.
Circulation Research|February 17, 2001
Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertensionI Duka, E Kintsurashvili, I Gavras, et al.
Pageof 32